Communiqués

27/08 Glycorex Transplantation (GTAB B): Signs distribution agreement in Malaysia for Glycosorb® ABO AQ
06/08 Glycorex Transplantation (GTAB B): Signs distribution agreement in Argentina for Glycosorb® ABO AQ
25/02 Glycorex Transplantation : Year end report 2025 (Glycorex Year end report 2025) PU
06/02 JHLT-recognised ABO-incompatible paediatric transplant study AQ
05/12 Glycorex Transplantation : Interim Report Quarter 3 (Glycorex Interim report Q3) PU
13/08/25 Glycorex Transplantation (GTAB B): First ABO-incompatible organ transplantion in Morocco with Glycosorb® ABO AQ
25/06/25 Glycorex Transplantation : Annual Report 2024 PU
28/02/25 Glycorex Transplantation (GTAB B): Enters distribution agreement in Greece for Glycosorb® ABO in the field of transfusion and transplantation AQ
27/02/25 Glycorex Transplantation : Year End Report 2024 PU
18/02/25 Glycorex Transplantation AB: First ABO-incompatible transplantation in Portugal with Glycosorb® ABO AQ
23/12/24 Glycorex Transplantation AB (GTAB B): First blood group-incompatible pediatric heart transplantation in Austria using Glycosorb® ABO AQ
13/09/24 Glycorex Transplantation AB (GTAB B): Results from Norwegian platelet evaluation presented at conference AQ
13/08/24 Glycorex Transplantation AB: First ABO-incompatible transplantation in Argentina with Glycosorb® ABO AQ
13/05/24 Glycosorb® ABO is pushing the boundaries in paediatric blood group incompatible heart transplantation AQ
08/05/24 First publication from South Africa and first stem cell transplantation performed in Mexico AQ
20/02/24 Glycorex Transplantation (GTAB B): Signs agreement with distributor in Romania AQ
29/11/23 Glycorex Transplantation AB: Entering into an agreement with Bio-Rad Laboratories, Inc. AQ
29/11/23 Glycorex Transplantation AB (publ): Interim Report January - September 2023 AQ
30/08/23 Glycorex Transplantation AB (publ): Interim Report January - June 2023 AQ
24/05/23 Glycorex Transplantation AB (publ): Interim Report January - March 2023 AQ
28/04/23 Annual Report 2022 Glycorex Transplantation AB (publ) AQ
09/03/23 Published study from the US shows promising results on the use of Glycosorb® ABO to provide low-titer group O whole blood AQ
20/02/23 The first blood group incompatible kidney transplant using Glycosorb® ABO performed in South Africa AQ
31/01/23 Glycorex strengthens the organization to place additional force behind the growth strategy Going 4 Growth AQ
24/11/22 Glycorex Transplantation AB (GTAB B): Interim report January - September 2022 AQ
Aucun résultat pour cette recherche